Targeting CREBBP/EP300 in cancer. Homo sapiens
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
Antiprolifereative effects of CREBBP/EP300 inhibitors were tested in human leukemia and lymphoma cell lines and the molecular mechanisms responsible for such effects were explored. Overall design: K562 cells were treated with CBP-30 (CREBBP/EP300 bromodomain inhibitor), C646 (CREBBP/EP300 HAT activity inhibitor) and JQ1 (BRD4 inhibitor) and changes in gene expression were evaluated by RNA-seq.
创建时间：
2016-01-27
